The size of the European Sleep Aids Market was worth USD 13.97 billion in 2020 and is estimated to be growing at a CAGR of 6.5%, to reach USD 19.14 billion by 2025.
The market is predicted to show significant potential in the coming years. The European Sleep Aids market has been increasing due to the rising geriatric population and increasing awareness among various organizations about sleep disorders. With the rise in the number of professionals working night shifts rescheduling their sleeping time, sleeping aids will likely gain interest in the next few years.
Sleep Aids are nothing but medical devices or drugs that help people to fall asleep. Lack of proper sleep cycle called sleep disorders to have negative effects on one’s health and work life. Sleep Disorders are generally caused due to changes in sleeping patterns caused by medical issues, psychiatric problems, and environmental issues.
The increase in alcohol, caffeine, and tobacco has been leading to sleep disorders among the population. It is one of the major factors driving the European sleeping aids market. Further, sleep disorder awareness initiatives by various organizations and increased demand for sleeping pills as a result of stressful modern lifestyles have also contributed to the rapid growth of the Europe Sleep Aids market. Apart from the drivers, the Sleep Aids market also faces some restraints and challenges, including side effects associated with sleeping aids medications and patent expiration of treatment pills for sleep disorders.
The European Sleep Aids market is segmented based on Sleep disorders, Products, and Medication types. Based on sleep disorder, the market is segmented under Sleep Apnea, Insomnia, Restless legs syndrome, Narcolepsy, and Sleepwalking. By product, the European Sleep Aids market is segmented into Medication and Sleep apnea devices, Mattresses & Pillows, Sleep Laboratories. Based on Medication types, the segmentation is done under Prescription-based Drugs, OTC drugs, and Herbal Drugs. Sleep apnea remains the fastest-growing segment than other sleep disorders, whereas Mattresses and pillows are expected to continue leading the market in the coming few years. Based on medication type, prescription medications hold the largest share in the European Sleep Aids market. Based on geographical analysis, the European Sleep Aids market is segmented under various countries, namely U.K, Spain, Germany, Italy, and France.
The major companies dominating the Europe Sleep Aids market are Sanofi, GlaxoSmithKline Plc, Cadwell, Merck & Co., Pfizer, Koninklijke Philips N.V. (Philips), Pfizer, SleepMed, DeVilbiss Healthcare LLC, Care Fusion Corporation, Natus Medical manufactures.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sleep Disorder
5.1.1 Introduction
5.1.2 Insomnia
5.1.3 Sleep Apnea
5.1.4 Restless legs syndrome
5.1.5 Narcolepsy
5.1.6 Sleep Walking
5.1.6 Y-o-Y Growth Analysis, By Sleep Disorder
5.1.7 Market Attractiveness Analysis, By Sleep Disorder
5.1.8 Market Share Analysis, By Sleep Disorder
5.2 Product
5.2.1 Introduction
5.2.2 Mattresses & Pillows
5.2.3 Sleep Laboratories
5.2.4 Medications
5.2.5 Sleep apnea devices
5.2.6 Y-o-Y Growth Analysis, By Product
5.2.7 Market Attractiveness Analysis, By Product
5.2.8 Market Share Analysis, By Product
5.3 Medication
5.3.1 Introduction
5.3.2 Prescription-based Drugs
5.3.3 OTC Drugs
5.3.4 Herbal Drugs
5.3.5 Y-o-Y Growth Analysis, By Medication
5.3.6 Market Attractiveness Analysis, By Medication
5.3.7 Market Share Analysis, By Medication
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Sleep Disorder
6.1.3.3 By Product
6.1.3.4 By Medication
6.1.3.5 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Sleep Disorder
6.1.4.3 By Product
6.1.4.4 By Medication
6.1.4.5 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Sleep Disorder
6.1.5.3 By Product
6.1.5.4 By Medication
6.1.5.5 By Indication
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Sanofi
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck & Co
8.3 Pfizer
8.4 Koninklijke Philips N.V.
8.5 GlaxoSmithKline Plc
8.6 Care Fusion Corporation
8.7 Cadwell
8.8 Sleepmed
8.9 Natus Medical Manufacturers
8.10 DeVilbiss Healthcare LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
